Hims Hers Health Inc (HIMS)

Hims & Hers Health, Inc. is a healthcare company listed on the NYSE under the ticker HIMS. It operates a consumer-focused health and wellness platform that connects patients with licensed healthcare professionals in the United States and several international markets, including the United Kingdom, Canada, Germany, the Republic of Ireland, France, and Spain. Through its websites and mobile app, the company provides prescription and non-prescription products, along with related services such as medical consultations, post-consultation support, and laboratory testing. Its branded offerings cover areas such as general wellness, skincare, sexual health, hair care, hormone health, weight loss, dermatology, and mental health. The company is based in San Francisco, California.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Next Earnings Date Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
NYSE-HIMS
$22.44
-19.8% Downside
Overvalued
$31.29
11.8% Upside
Fair
Good
0.0%
November 9, 2026
20.2x
2.5x
6.53 B
7.236 B
19.2%
91.6%
2.0
-58.5%
Valuation • Fair Value

Hims Hers Health Inc (NYSE-HIMS) Fair Value by Valuation Model

Review the available estimates for Hims Hers Health Inc (NYSE-HIMS), including DCF Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$22.44

Estimated downside of 19.8% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

$22.97

Discounted cash flow valuation reference.

Comps Fair Value

$21.91

Comparable-company valuation reference.

Analyst Price Target

$31.29

Analysts imply upside of 11.8%.

How to read these valuation models

Use the 5 available valuation references for Hims Hers Health Inc (NYSE-HIMS) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Hims Hers Health Inc (NYSE-HIMS)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

2.578 B

Current operating scale indicator.

Revenue Forecast

3.202 B

Forward revenue estimate.

EBITDA

-10.177 M

Current operating profitability reference.

EBITDA Forecast

296.3 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Hims Hers Health Inc (NYSE-HIMS) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Hims Hers Health Inc (NYSE-HIMS)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Good

Positive financial-health read.

Piotroski Score

4

Mid-range quality score.

Beneish M-Score

37.37

Higher caution zone on this screen.

Altman Z-Score

2.0

Intermediate risk zone.

FCF / Net Income

-58.5%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Hims Hers Health Inc (NYSE-HIMS). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Hims Hers Health Inc (NYSE-HIMS)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 9, 2026

Days to Earnings

52

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Hims Hers Health Inc (NYSE-HIMS), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Hims Hers Health Inc (NYSE-HIMS) Stock Forecast & Technical Outlook

Review Hims Hers Health Inc (NYSE-HIMS) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Hims Hers Health Inc (NYSE-HIMS) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Hims Hers Health Inc (NYSE-HIMS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Sell

The daily technical read for Hims Hers Health Inc (NYSE-HIMS) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Hims Hers Health Inc (NYSE-HIMS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Neutral

The monthly technical read for Hims Hers Health Inc (NYSE-HIMS) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Hims Hers Health Inc (NYSE-HIMS)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, Hims Hers Health Inc (NYSE-HIMS) has a Hold consensus, with 1 buy, 13 hold and 0 sell recommendations in the current data set.

Buy 1
Hold 13
Sell 0
FAQ Fast Investor Answers

Hims Hers Health Inc (NYSE-HIMS) Stock FAQ

Data-supported answers about Hims Hers Health Inc (NYSE-HIMS), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$22.44
Estimated downside 19.8%
Valuation Rating
Overvalued
Estimated downside of 19.8%
Analyst Target
$31.29
Implied upside 11.8%
Financial Health
Good
Current financial-health read

The current fair value estimate for Hims Hers Health Inc (NYSE-HIMS) is $22.44. This implies an estimated downside of 19.8% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 19.8% versus the current market price.

The available analyst price target for Hims Hers Health Inc (NYSE-HIMS) is $31.29. The analyst target implies estimated upside of 11.8%.

The current financial health read for Hims Hers Health Inc (NYSE-HIMS) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Hims Hers Health Inc (NYSE-HIMS) is November 9, 2026.

The latest available data indicates no current dividend yield for Hims Hers Health Inc (NYSE-HIMS).

The current market capitalization listed for Hims Hers Health Inc is 6.53 B.

The current enterprise value listed for Hims Hers Health Inc is 7.236 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Hims Hers Health Inc is NYSE-HIMS, and the stock is listed on NYSE.

Hims Hers Health Inc (NYSE-HIMS) is listed on NYSE.

The current debt-to-total-capital ratio listed for Hims Hers Health Inc is 19.2%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Hims Hers Health Inc is 91.6%. Free float helps investors understand how much of the share base is available for public trading.